Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy.
Journal of internal medicine 2012 May 271 (5): 499-509.
Huang C-N, Huang S-P, Pao J-B, Hour T-C, Chang T-Y, Lan Y-H, Lu T-L, Lee H-Z, Juang S-H, Wu P-P, Huang C-Y, Hsieh C-J, Bao B
Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
PloS one 2011 6 (7): e21731.
Wentzensen Nicolas, Black Amanda, Jacobs Kevin, Yang Hannah P, Berg Christine D, Caporaso Neil, Peters Ulrike, Ragard Lawrence, Buys Saundra S, Chanock Stephen, Hartge Patric